Managers
Managers | Title | Age | Since |
---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Joann Nestor
SEC | Corporate Secretary | - | - |
Corporate Officer/Principal | - | - | |
Timothy Harris
PRN | Corporate Officer/Principal | 74 | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Philippe Sauvage
BRD | Director/Board Member | - | 18-03-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,223,644 | 107,993,510 ( 99.79 %) | 0 | 99.79 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |